Number of Patients with Complete Response (CR) 6 months [clinicaltrials_resource:bffd20c5b83770238790f4814057dab1]
Criteria for response as per the international working group for Myelodysplastic Syndrome (MDS) and acute myeloid leukemia (AML). Responders are patients who obtain a CR, CRi, or PR, with or without cytogenetic response, hematologic improvements, and morphologic leukemia-free state.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of Patients with Complete Response (CR) 6 months [clinicaltrials_resource:bffd20c5b83770238790f4814057dab1]
Criteria for response as per the international working group for Myelodysplastic Syndrome (MDS) and acute myeloid leukemia (AML). Responders are patients who obtain a CR, CRi, or PR, with or without cytogenetic response, hematologic improvements, and morphologic leukemia-free state.
Bio2RDF identifier
bffd20c5b83770238790f4814057dab1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bffd20c5b83770238790f4814057dab1
measure [clinicaltrials_vocabulary:measure]
Number of Patients with Complete Response (CR)
time frame [clinicaltrials_vocabulary:time-frame]
description
Criteria for response as per t ...... rphologic leukemia-free state.
identifier
clinicaltrials_resource:bffd20c5b83770238790f4814057dab1
title
Number of Patients with Complete Response (CR) 6 months
@en
type
label
Number of Patients with Comple ...... d20c5b83770238790f4814057dab1]
@en